Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Kinross Gold | 5.58% | $3.44M | $41.74B | 204.92% | 81 Outperform | |
| Novartis AG | 4.48% | $2.76M | CHF242.43B | 28.84% | 80 Outperform | |
| Rio Tinto Limited | 4.38% | $2.70M | AU$238.88B | 46.67% | 78 Outperform | |
| Nutrien | 4.20% | $2.59M | $33.99B | 35.39% | 75 Outperform | |
| BAE Systems | 4.19% | $2.58M | £61.53B | 83.55% | 61 Neutral | |
| Sumitomo Mitsui Financial Group | 3.60% | $2.22M | ¥22.61T | 54.61% | 77 Outperform | |
| Mitsubishi Electric | 3.29% | $2.03M | ¥11.82T | 120.26% | 72 Outperform | |
| Rexel SA | 3.14% | $1.93M | €10.60B | 35.86% | 65 Neutral | |
| AstraZeneca | 3.08% | $1.90M | $323.92B | 30.42% | 80 Outperform | |
| Nordea Bank Abp | 2.97% | $1.83M | kr611.49B | 47.65% | ― |